TCG Crossover Management’s Jade Biosciences JBIO Stock Holding History

TCG Crossover Management’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-64,023	Closed	-$640K	–	41
2025 Q2	$640K	Hold	64,023	–	–	0.07%	36
2025 Q1	$5.62M	Hold	64,023	–	–	0.77%	30
2024 Q4	$5.94M	Hold	64,023	–	–	0.58%	34
2024 Q3	$4.68M	Hold	64,023	–	–	0.4%	31
2024 Q2	$3.72M	Buy	64,023 +1,129	+2%	+$749K	0.39%	28
2024 Q1	$65.1M	Hold	62,894	–	–	5.15%	6
2023 Q4	$49.8M	Hold	62,894	–	–	5.52%	6
2023 Q3	$29.9M	Hold	62,894	–	–	4.4%	9
2023 Q2	$37.8M	Buy	62,894 +32,000	+104%	+$20.5M	6.19%	5
2023 Q1	$21.8M	Hold	30,894	–	–	4.25%	10
2022 Q4	$31.7M	Buy	30,894 +3,478	+13%	+$2.53M	5.59%	7
2022 Q3	$15.9M	Buy	27,416 +2,000	+8%	+$1.34M	4.77%	9
2022 Q2	$13.9M	Hold	25,416	–	–	5.91%	9
2022 Q1	$16.3M	Buy	25,416 +1,035	+4%	+$402K	6.55%	7
2021 Q4	$10.1M	Buy	+24,381	New	+$12.3M	4.71%	10

Other funds holding JBIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return